Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-28

Clinical Trial Update: Management of Volume Overload HF Patients by Individual DSR Treatment adJustment-a clinicAl inVestigation of InfusatE2.0 [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for InfusatE2.0 investigating individual device-based adjustments to manage volume overload in heart failure patients across Phase 1 and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • InfusatE2.0

Snippet

Sponsor: Sequana Medical N.V. | Conditions: Heart Failure, Volume Overload | Phase 1, Phase 2 | Status: UNKNOWN